Cerebral vasospasm: looking beyond vasoconstriction

Trends in Pharmacological Sciences

Volumn 28, Issue 6, 2007, Pages 252-256

  Hansen Schwartz, Jacob ^a   Vajkoczy, Peter ^b   Macdonald, Robert Loch ^c   Pluta, Ryszard M ^d   Zhang, John H ^e  

^a Rigshospitalet   (Denmark)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^e LOMA LINDA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLAZOSENTAN;

APOPTOSIS; ARTICLE; BLOOD BRAIN BARRIER; BRAIN ISCHEMIA; BRAIN VASOSPASM; CLINICAL TRIAL; HUMAN; INFLAMMATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; SPREADING CORTICAL DEPRESSION; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME; VASOCONSTRICTION;

BLOOD-BRAIN BARRIER; CALCIUM; CEREBROVASCULAR CIRCULATION; HUMANS; INTRACRANIAL ANEURYSM; MUSCLE, SMOOTH, VASCULAR; PROTEIN KINASE C; RHO-ASSOCIATED KINASES; VASOCONSTRICTION; VASOSPASM, INTRACRANIAL;

EID: 34249333412     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tips.2007.04.002     Document Type: Article

References (39)

1. Mendelow A.D. Pathophysiology of delayed ischaemic dysfunction after subarachnoid haemorrhage: experimental and clinical data. Acta Neurochir. Suppl. (Wien) 45 (1988) 7-10
2. Kassell N.F., et al. The International Cooperative Study on the Timing of Aneurysm Surgery. Part 1: overall management results. J. Neurosurg. 73 (1990) 18-36
3. Mayberg M.R. Cerebral vasospasm. Neurosurg. Clin. N. Am. 9 (1998) 615-627
4. Weir B., et al. Time course of vasospasm in man. J. Neurosurg. 48 (1978) 173-181
5. Dorsch N. Therapeutic approaches to vasospasm in subarachnoid hemorrhage. Curr. Opin. Crit. Care 8 (2002) 128-133
6. Suarez J., et al. Aneurysmal subarachnoid hemorrhage. N. Engl. J. Med. 354 (2005) 387-396
7. Vajkoczy P., et al. Clazosentan (AXV-034343), a selective endothelin A receptor antagonist, in the prevention of cerebral vasospasm following severe aneurysmal subarachnoid hemorrhage: results of a randomized, double-blind, placebo-controlled, multicenter Phase IIa study. J. Neurosurg. 103 (2005) 9-17
8. Macdonald R.L., et al. Randomized trial of clazosentan for prevention of vasospasm after aneurysmal subarachnoid hemorrhage. Stroke 38 (2007) 462
9. 2+ is essential for the development of cerebral vasospasm. Curr. Vasc. Pharmacol. 2 (2004) 13-21
10. Kim I., et al. Thin and thick filament regulation of contractility in experimental cerebral vasospasm. Neurosurgery 46 (2000) 440-446
11. Zhang Z.D., et al. Vasospasm in monkeys resolves because of loss of and encasement of subarachnoid blood clot. Stroke 32 (2001) 1868-1874
12. Klimo Jr. P., et al. Marked reduction of cerebral vasospasm with lumbar drainage of cerebrospinal fluid after subarachnoid hemorrhage. J. Neurosurg. 100 (2004) 215-224
13. Macdonald R.L., and Weir B.K. A review of hemoglobin and the pathogenesis of cerebral vasospasm. Stroke 22 (1991) 971-982
14. Clark J.F., and Sharp F.R. Bilirubin oxidation products (BOXes) and their role in cerebral vasospasm after subarachnoid hemorrhage. J. Cereb. Blood Flow Metab. 26 (2006) 1223-1233
15. 2+]i elevation in cerebral smooth muscle cells. Am. J. Physiol. 269 (1995) H1874-H1890
16. Macdonald R.L., et al. Role of adenosine 5′-triphosphate in vasospasm after subarachnoid hemorrhage: human investigations. Neurosurgery 48 (2001) 854-862
17. Laher I., and Zhang J.H. Protein kinase C and cerebral vasospasm. J. Cereb. Blood Flow Metab. 21 (2001) 887-906
18. Chrissobolis S., and Sobey C.G. Recent evidence for an involvement of rho-kinase in cerebral vascular disease. Stroke 37 (2006) 2174-2180
19. Pluta R.M. Delayed cerebral vasospasm and nitric oxide: review, new hypothesis, and proposed treatment. Pharmacol. Ther. 105 (2005) 23-56
20. Santhanam A.V., et al. Role of endothelial NO synthase phosphorylation in cerebrovascular protective effect of recombinant erythropoietin during subarachnoid hemorrhage-induced cerebral vasospasm. Stroke 36 (2005) 2731-2737
21. McGirt M.J., et al. Galbraith Award: simvastatin attenuates experimental cerebral vasospasm and ameliorates serum markers of neuronal and endothelial injury in patients after subarachnoid hemorrhage: a dose-response effect dependent on endothelial nitric oxide synthase. Clin. Neurosurg. 52 (2005) 371-378
22. Hansen-Schwartz J., et al. Human endothelin subtype A receptor enhancement during tissue culture via de novo transcription. Neurosurgery 50 (2002) 127-133
23. Sehba F.A., and Bederson J.B. Mechanisms of acute brain injury after subarachnoid hemorrhage. Neurol. Res. 28 (2006) 381-398
24. Ostrowski R.P., et al. Molecular mechanisms of early brain injury after subarachnoid hemorrhage. Neurol. Res. 28 (2006) 399-414
25. Prunell G.F., et al. Inflammation in the brain after experimental subarachnoid hemorrhage. Neurosurgery 56 (2005) 1082-1092
26. Dreier J.P., et al. Products of hemolysis in the subarachnoid space induce cortical spreading ischemia and focal necrosis in rats, a model for delayed ischemic neurological deficits after subarachnoid hemorrhage?. J. Neurosurg. 93 (2000) 668-676
27. Cahill J., et al. Mechanisms of early brain injury after subarachnoid hemorrhage. J. Cereb. Blood Flow Metab. 26 (2006) 1341-1353
28. Gallia G.L., and Tamargo R.J. Leukocyte-endothelial cell interactions in chronic vasospasm after subarachnoid hemorrhage. Neurol. Res. 28 (2006) 750-758
29. Kasuya H., and Shimizu T. Activated complement components C3a and C4a in cerebrospinal fluid and plasma following subarachnoid hemorrhage. J. Neurosurg. 71 (1989) 741-746
30. Fassbender K., et al. Inflammatory cytokines in subarachnoid haemorrhage: association with abnormal blood flow velocities in basal cerebral arteries. J. Neurol. Neurosurg. Psychiatry 70 (2001) 534-537
31. Mack W.J., et al. Outcome prediction with serum intercellular adhesion molecule-1 levels after aneurysmal subarachnoid hemorrhage. J. Neurosurg. 96 (2002) 71-75
32. Weyer G.W., et al. Evidence-based cerebral vasospasm management. Neurosurg. Focus 21 (2006) E8
33. Hashimoto T., et al. Intracranial aneurysms: links among inflammation, hemodynamics and vascular remodeling. Neurol. Res. 28 (2006) 372-380
34. Provencio J.J., and Vora N. Subarachnoid hemorrhage and inflammation: bench to bedside and back. Semin. Neurol. 25 (2005) 435-444
35. Neil-Dwyer G., et al. Delayed cerebral ischaemia: the pathological substrate. Acta Neurochir. (Wien) 131 (1994) 137-145
36. Dreier J.P., et al. Delayed ischaemic neurological deficits after subarachnoid haemorrhage are associated with clusters of spreading depolarizations. Brain 129 (2006) 3224-3237
37. Windmuller O., et al. Ion changes in spreading ischaemia induce rat middle cerebral artery constriction in the absence of NO. Brain 128 (2005) 2042-2051
38. Harder D.R., et al. Possible cellular mechanism for cerebral vasospasm after experimental subarachnoid hemorrhage in the dog. J. Clin. Invest. 80 (1987) 875-880
39. Faraci F.M., and Sobey C.G. Role of potassium channels in regulation of cerebral vascular tone. J. Cereb. Blood Flow Metab. 18 (1998) 1047-1063